History
Learn more about the history of Ventinova Medical
From the beginning, we believe in creating a new ventilation concept through revolutionary products. Products that will set a new ventilation standard worldwide, providing substantial benefits in various fields of surgery and promise better ventilation of patients in the operating room. We invite you to accompany us on our journey to redefine ventilation!

The beginning of the Ventinova journey:
Founding of Dolphys
See full story
The Ventinova journey begins with the founding of Dolphys. The company started by developing a drug delivery system. A few years later the idea of manual ventilator Ventrain was born.
Collaboration Dirk van Asseldonk and
Prof. Dr. med. Dietmar Enk
See full story
Dirk van Asseldonk (left) is a successful entrepreneur, especially interested in ideas at the intersection of technology, medicine and economics. He thinks it is important to do business in markets that really matter, such as a medical innovation that is life-saving. He met Prof. Dr. med. Enk for the first time in 2007 because Dolphys developed a drug release implant, of which Maastricht University Medical Center (MUMC) in The Netherlands was a partner. Prof. Dr. med. Dietmar Enk, at the time anesthesiologist at MUMC, is responsible for several inventions. He wanted to be more involved in the development of his inventions and found a suitbale partner in Ventinova Medical (back then Dolphys). In 2008 Dietmar and Dirk started the further development of manual ventilator Ventrain.
Nomination Herman Wijffels Innovatie Prijs
In 2008 Dirk van Asseldonk was nominated for the Rabobank Herman Wijffels Innovatie Prijs with ActivJet, the precursor to Ventrain. This Dutch Herman Wijffels Innovation Prize aims for sustainable innovations.


A new collaboration starts
See full story
Collaboration starts with Prof. Dr. Med. Dietmar Enk.

CE marking of manual ventilator Ventrain
See full story
CE marking of cricothyrotomy catheter Cricath
See full story


CE marking of Cricath
See full story

Ventinova Medical was founded
See full story
In 2013 we enter a new period: Ventinova Medical is founded. The name is a composition of venti (ventilation) and nova (new).
FCV® ventilation presented at Euroanaesthesia
First European Investment Round for Ventinova


1st investment round
See full story
Ventinova receives 1.9 million Euros funding from the European Union’s Horizon 2020 research and innovation programme.

CE marking of ultrathin ventilation tube Tritube
See full story
First clinical in human use of mechanical ventilator Evone and ultrathin ventilation tube Tritube
See full story
CE marking of Evone
Industry Symposium Euroanaesthesia 2017
Ventinova Medical organized a crowded Industry Symposium at Euroanaesthesia 2017 on the Update and new perspectives in airway management and mechanical ventilation. Prof. Dr. Carin Hagberg, UT MD Anderson Cancer Center, Houston USA, Prof. Dr. Luciano Gattinoni, University of Goettingen, Germany and Prof. Dr. med. Dietmar Enk, University Hospital of Muenster, Germany, gave their vision on the subject.
First clinical in human use of Evone
First clinical in human use of Tritube


First clinical in human use of Ventrain and Tritube
See full story
CE marking of Evone
Industry Symposium Euroanaesthesia 2017
Ventinova Medical organized a crowded Industry Symposium at Euroanaesthesia 2017 on the Update and new perspectives in airway management and mechanical ventilation. Prof. Dr. Carin Hagberg, UT MD Anderson Cancer Center, Houston USA, Prof. Dr. Luciano Gattinoni, University of Goettingen, Germany and Prof. Dr. med. Dietmar Enk, University Hospital of Muenster, Germany, gave their vision on the subject.
First clinical in human use of Evone
First clinical in human use of Tritube

First Evone sold to a hospital in The Netherlands.
See full story
Ventinova’s first Evone is sold to Amsterdam University Medical Center, The Netherlands.
Evone is already used in more than 40 hospitals in 11 countries
See full story
Evone is already used in more than 40 hospitals in 11 countries during a wide variety of surgeries.
Preclinical study in pigs comparing FCV® to PCV ventilation
Cinematic CT scan after 10 h ventilation, pilot study 10/2018 – 01/2019. Universitätsklinikum Innsbruck.
FCV is on the right.
Prof. Dr. med. Christian Byhahn, University Hospital Oldenburg, Germany is very proud to be the owner of ventilator Evone (left on the photo)
Hamad Medical Corporation (HMC) Qatar: the first to introduce Evone in their daily clinical practice in the Middle East
The anesthesiology team led by Prof. Dr. Marco Marcus achieved regional recognition for their fantastic work done, not only in clinic but even more in setting up an airway management training center, in which Evone with its FCV® technology and the associated ultra-thin Tritube play an important role. Doctors Nabil Shallik and Marcus Lance value the experienced surgical benefits of this “only ventilation appliance of its type”. Furthermore, they acknowledge that Evone may considerably reduce the number of lung complications related to conventional artificial ventilation. They state that “The technology has the potential to be used in various fields of surgery.”


Evone is used in more than 40 hospitals in over 10 European countries
See full story
What’s next?
Sign up for our newsletter and we’ll keep you posted about our latest developments.
LATEST NEWS
Webinar 17th of December 2020 17:00 – 18:00 hours CET
Subject: Evone Flow Controlled Ventilation during endoscopic upper airway surgery. On the 17th of December 2020 from 17:00 - 18:00 hours CET Dr. Meulemans from UZ Leuven will share his clinical experience on using Tritube and Evone during laryngeal...
SIGN UP FOR OUR NEWSLETTER:
CONTACT US
Ventinova Medical
Meerenakkerplein 7
5652 BJ Eindhoven (NL)
T. +31 (0)40 7516020
E. info@ventinova.nl
Chamber of Commerce: 58307834